A 1‐year and 4‐month‐old child with mucopolysaccharidoses type II: A clinical case report from Ethiopia
Abstract Mucopolysaccharidoses (MPSs) are a class of lysosomal storage disorders resulting in progressive disease manifestations and are caused by pathogenic variants in genes coding for enzymes needed to degrade glycosaminoglycans. While most of the seven MPSs are autosomal recessive disorders, MPS...
Guardado en:
Autores principales: | Solomie Jebessa Deribessa, Mekdes Endale Bisrat, Zewdu Terefework, Shane C. Quinonez |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wiley
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1dc4fdd3a9c3433189ab241c16aa614d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Loss of Function of Mutant IDS Due to Endoplasmic Reticulum-Associated Degradation: New Therapeutic Opportunities for Mucopolysaccharidosis Type II
por: Koji Matsuhisa, et al.
Publicado: (2021) -
Detection of Mosaic Variants in Mothers of MPS II Patients by Next Generation Sequencing
por: Alice Brinckmann Oliveira Netto, et al.
Publicado: (2021) -
Divergent developmental trajectories in two siblings with neuropathic mucopolysaccharidosis type II (Hunter syndrome) receiving conventional and novel enzyme replacement therapies: A case report
por: Kazuyoshi Tomita, et al.
Publicado: (2021) -
Human sulfatase transiently and functionally active expressed in E. coli K12
por: Poutou-Piñales,Raúl A, et al.
Publicado: (2010) -
Glycosaminoglycans (GAGs) determination in healthy and damaged equine articular cartilage
por: Adarmes,Héctor, et al.
Publicado: (2017)